Ehrlichiosis

Overview

Ehrlichiosis is a group of acute infections caused by intracellular bacteria in the genus Ehrlichia. In the United States, E. chaffeensis causes most reported cases, while E. ewingii and E. muris eauclairensis cause smaller numbers. Infection is acquired mainly through the bite of an infected tick and typically produces a nonspecific febrile illness. ^{[1] [2]}

The organisms infect white blood cells and trigger systemic inflammation. Laboratory abnormalities commonly include leukopenia, thrombocytopenia and elevated liver enzymes. Because early illness resembles influenza, COVID-19, other tick-borne infections or many viral syndromes, recognition depends heavily on exposure history, season, geography and the pattern of laboratory findings. ^{[1] [2]}

Ehrlichiosis is especially important because treatment is time sensitive and confirmatory tests can be negative early. A patient who develops fever, severe headache and cytopenias after plausible tick exposure may need empiric doxycycline before PCR or serology is finalized. Waiting for a rash is unreliable because rash is absent in many adults. ^{[1] [2] [3]}

Symptoms and warning signs

Symptoms usually begin within about one to two weeks after a tick bite and can include fever, chills, headache, marked fatigue, muscle aches, nausea, vomiting, diarrhea and loss of appetite. Some people develop rash, particularly children. The tick bite itself is often not remembered, so absence of a known bite does not exclude the infection. ^{[1] [2]}

Severe ehrlichiosis can cause respiratory distress, encephalopathy or meningoencephalitis, bleeding problems, shock, kidney injury or multiorgan failure. Confusion, severe weakness, difficulty breathing, persistent vomiting, fainting or rapidly worsening illness should prompt emergency evaluation. Older age and immune compromise increase the risk of severe disease. ^{[1] [2]}

Diagnosis

Diagnosis is based on the clinical picture plus laboratory testing. A complete blood count and liver panel can show the characteristic combination of low white cells, low platelets and transaminase elevation, although normal results do not exclude early disease. PCR on whole blood is most useful during the first week of illness and before prolonged antibiotic exposure. ^{[1] [2]}

Serologic testing with indirect immunofluorescence is usually interpreted using paired acute and convalescent samples because antibodies may be absent early. A single negative acute antibody test does not rule out ehrlichiosis. Blood-smear examination can occasionally show intracellular morulae, but sensitivity is too low to rely on microscopy alone. ^{[1] [2] [3]}

Other possibilities include anaplasmosis, Rocky Mountain spotted fever, Lyme disease, babesiosis, viral infections, sepsis and hematologic disorders. Coinfection is possible in regions where tick vectors overlap. The practical diagnostic question is often whether the illness is compatible enough with a treatable tick-borne infection to justify prompt doxycycline while testing proceeds. ^{[2] [3]}

Causes, risk factors and clinical context

Risk is highest during months when vector ticks are active and in regions where the relevant tick species are established. Outdoor activity in wooded or brushy areas increases exposure. People may be infected around the home as well as during hiking. Older adults and people with weakened immune systems have a higher likelihood of severe outcomes. ^{[1] [2]}

With early treatment, fever often improves within one to two days. Lack of clinical response should prompt reconsideration of the diagnosis, complications or coinfection. Untreated illness can worsen over the first week and become life threatening. Most treated patients recover fully, although severe cases may require hospitalization and prolonged recovery. ^{[1] [2] [3]}

Complications and why the diagnosis matters

Complications reflect widespread inflammation and organ dysfunction and can include acute respiratory distress, neurologic involvement, disseminated intravascular coagulation, kidney injury, myocarditis and shock. Delayed doxycycline is associated with worse clinical outcomes, which is why treatment decisions are based on clinical suspicion rather than laboratory confirmation alone. ^{[1] [2]}

Most people treated promptly recover, but risk is not uniform. Severe disease is more likely with advanced age, immune suppression and treatment delay. Persistent fatigue can continue after the acute infection even when laboratory values normalize. True chronic active ehrlichiosis after adequate treatment is not the usual explanation for nonspecific long-term symptoms. ^{[1] [2] [3]}

Treatment and management

Doxycycline is the treatment of choice for suspected and confirmed ehrlichiosis in adults and children of all ages. Therapy should begin as soon as the disease is clinically suspected and should not be delayed for PCR or serology. The exact duration is determined by clinical response and guideline recommendations, including coverage for possible overlapping tick-borne infections where relevant. ^{[1] [2]}

Hospitalized patients may need intravenous fluids, oxygen, treatment of organ dysfunction and monitoring of blood counts, liver enzymes and renal function. Broad-spectrum sepsis management may be appropriate before the diagnosis is clear. Clinical improvement after doxycycline supports the diagnosis but is not itself a definitive test. ^{[1] [2] [3]}

Short courses of doxycycline are recommended for children with suspected serious rickettsial disease because the benefit of timely treatment outweighs concerns associated with older tetracycline data. Patients should not wait for a remembered tick bite or a positive antibody test if the clinical syndrome is strongly compatible. ^{[1] [2]}

Follow-up, recovery and prevention

Follow-up after uncomplicated illness is usually clinical. Persistent fever after appropriate therapy should trigger reassessment. Severe disease may require repeat blood counts, liver tests, kidney function and organ-specific follow-up. Convalescent serology can help confirm the diagnosis for surveillance or when the initial PCR was negative. ^{[1] [2]}

There is no vaccine. Prevention relies on reducing tick exposure: use repellents, wear protective clothing, perform tick checks after outdoor activity, shower after returning indoors and manage tick habitat around homes. Prompt tick removal reduces risk for some tick-borne infections, although exact transmission timing varies by organism. ^{[1] [2] [3]}

Special situations and care pathway

Pregnancy and serious drug allergy require clinician-guided treatment decisions, but potentially severe ehrlichiosis still needs prompt effective therapy. Immunocompromised people can have more severe disease and may not mount typical antibody responses. In transplant recipients, transfusion and organ-transmission events have been reported rarely. ^{[1] [2] [3]}

A practical pathway is to recognize the compatible febrile syndrome, order CBC and metabolic/liver tests, send PCR early, start doxycycline when suspicion is meaningful and use paired serology for confirmation. Hospitalize patients with organ dysfunction, severe cytopenias, neurologic changes or inability to maintain hydration. ^{[1] [2]}

When to seek urgent medical care

Seek urgent care for fever after tick exposure when there is confusion, difficulty breathing, fainting, severe headache, persistent vomiting, bleeding, very low blood pressure or rapid clinical decline. Early severe ehrlichiosis can look like sepsis and should be treated accordingly. ^{[1] [2]}

Sources

1. CDC — Clinical Overview of Ehrlichiosis
2. CDC — About Ehrlichiosis
3. CDC — Clinical Care of Ehrlichiosis

This article is based on trusted medical sources and is awaiting clinician review. It is not a substitute for personalized medical advice.